Department of Surgical Research and Transplantology, Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Surg Oncol. 2010 Dec;19(4):e85-94. doi: 10.1016/j.suronc.2009.07.003. Epub 2009 Aug 7.
The anti-tumor vaccination is burdened by low recruitment rate of intravenously administered in vitro primed DC in liver metastases and lack of supplying them continuously in large numbers. Therefore, it seemed rational to create a model of in vivo vaccination with specifically primed splenic DC and cytotoxic T lymphocytes being continuously supplied to the liver vascular bed. The question we raised was whether anti-tumor immunized splenic DC flowing to liver metastases could adhere to and be cytotoxic to tumor cells. We immunized rats with CC531 tumor cells and stimulated them with Escherichia coli LPS. Subsequently, spleen DC-enriched population was isolated, its activation by LPS, adherence to CC531 cells and cytotoxicity were measured. Spleen cells home to the liver reaching it via splenic vein. These cells can be retrieved by simple washout of liver sinusoids (liver sinusoidal washout cells - LSWC). Their adherence to and cytotoxicity against CC531 cells were evaluated. Moreover, in vitro adherence of splenic DC-enriched cells and LSWC to CC531 liver tumor sections was measured. We found that in vivo immunization of splenic population containing DC, NK cells and lymphocytes with CC531 cells and stimulation with LPS activated these cells but did not significantly increase the cytotoxicity against CC531 cells. There was also no increase in cytotoxicity of LSWC. Adhesion of splenic DC and LWSC to liver CC531 metastases on cryosections was higher than to the adjacent liver tissue. However, it was more expressed on tumor stromal than neoplastic cells. The level of splenic Treg cells down-regulating immune response was found only slightly increased after immunization. Taken together, in the model of in vivo immunization against CC531 cells, low level of spleen DC and spleen-derived LSWC cytotoxicity as well as adherence rate to tumor cells were observed. More effective methods of immunizing splenic DC overcoming the suppressive mechanisms should be looked for.
肿瘤的免疫治疗受到静脉给予的体外培养的树突状细胞(DC)在肝转移灶中募集率低以及无法大量持续供应的限制。因此,创建一种体内免疫接种模型似乎是合理的,该模型用特异性致敏的脾 DC 和细胞毒性 T 淋巴细胞持续供应至肝血管床。我们提出的问题是,流向肝转移灶的抗肿瘤免疫的脾 DC 是否能够黏附和杀伤肿瘤细胞。我们用 CC531 肿瘤细胞免疫大鼠,并刺激它们用大肠杆菌 LPS。随后,分离富含脾 DC 的群体,测量其 LPS 的激活、对 CC531 细胞的黏附和细胞毒性。脾细胞通过脾静脉归巢至肝脏。可以通过简单地冲洗肝窦(肝窦冲洗细胞-LSWC)回收这些细胞。评估它们对 CC531 细胞的黏附和细胞毒性。此外,还测量了富含脾 DC 的细胞和 LSWC 在体外对 CC531 肝肿瘤切片的黏附作用。我们发现,用 CC531 细胞和 LPS 对包含 DC、NK 细胞和淋巴细胞的脾细胞进行体内免疫可激活这些细胞,但对 CC531 细胞的细胞毒性没有显著增加。LSWC 的细胞毒性也没有增加。脾 DC 和 LSWC 对冷冻切片上肝 CC531 转移灶的黏附高于对邻近肝组织的黏附。然而,它在肿瘤基质上的表达高于肿瘤细胞。免疫后仅发现调节免疫反应的脾 Treg 细胞的水平略有增加。总之,在 CC531 细胞的体内免疫模型中,观察到脾 DC 和脾源性 LSWC 的细胞毒性以及对肿瘤细胞的黏附率低。应寻找更有效的免疫脾 DC 的方法来克服抑制机制。